Alexander Kupferthaler
Overview
Explore the profile of Alexander Kupferthaler including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
18
Citations
165
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Tatalovic S, Doleschal B, Kupferthaler A, Grundner S, Burghofer J, Webersinke G, et al.
Cancers (Basel)
. 2024 Dec;
16(23).
PMID: 39682148
Methods: ctDNA detection (ddPCR) was carried out serially in 37 matched tissue (NGS) patients with mGEC prior to systemic treatment initiation and every two weeks thereafter until restaging (n =...
2.
Doleschal B, Kirchweger P, Schwendinger S, Kupferthaler A, Burghofer J, Webersinke G, et al.
Ther Adv Med Oncol
. 2023 Oct;
15:17588359231200462.
PMID: 37786537
Background: Serial analysis of circulating tumor DNA (ctDNA) levels is a promising tool for both relapse prediction in the curative setting, as well as predicting clinical benefit from systemic treatment...
3.
Kupferthaler A, Hauck S, Schwarz M, Kern M, Deinsberger J, Dachs T, et al.
J Endovasc Ther
. 2023 Jan;
31(5):821-830.
PMID: 36680393
Purpose: In penetrating aortic ulcers (PAUs), limited data support tubular thoracic endovascular aortic repair (TEVAR) as a viable treatment option. For treatment of more proximal PAUs, hybrid approaches and-more recently-scalloped...
4.
Kirchweger P, Kupferthaler A, Burghofer J, Webersinke G, Jukic E, Schwendinger S, et al.
Front Oncol
. 2022 Sep;
12:902177.
PMID: 36110940
Introduction: Pretherapeutic detectable circulating tumor DNA (ctDNA) represents a promising prognostic biomarker for predicting relapse and overall survival in patients with metastatic pancreatic cancer. However, the prognostic value of ctDNA...
5.
Hauck S, Kupferthaler A, Kern M, Rousseau H, Ferrer C, Iwakoshi S, et al.
J Thorac Cardiovasc Surg
. 2022 May;
164(5):1379-1389.e1.
PMID: 35534283
Objective: For thoracic endovascular aortic repair of the arch, branched and fenestrated endografts are available with different limitations regarding anatomy and extent of the pathology. Comparisons are lacking in the...
6.
Kirchweger P, Wundsam H, Bosse F, Kupferthaler A, Huemer R, Fugger R
J Vasc Surg Cases Innov Tech
. 2022 May;
8(2):227-231.
PMID: 35493338
bacteremia is a rare (72 cases reported) aneurysm-inducing disease that has resulted in a 6-month mortality of 100% when treated conservatively. We report the case of a patient who was...
7.
Hauck S, Eilenberg W, Kupferthaler A, Kern M, Dachs T, Wressnegger A, et al.
Cardiovasc Intervent Radiol
. 2022 Apr;
45(6):744-751.
PMID: 35391546
Purpose: To compare bridging stent graft (BSG) implantation in downward oriented branches in branched endovascular aortic repair (bEVAR), using a commercially available steerable sheath from an exclusively femoral access (TFA)...
8.
Kirchweger P, Wundsam H, Bosse F, Fritz A, Kratzer T, Kalteis M, et al.
J Vasc Surg
. 2022 Mar;
76(2):595-604.e1.
PMID: 35358668
Background: Clostridium septicum bacteremia is often associated with occult malignancies (approximately 80%), especially of the right colon. Furthermore, inflammation of the aortic wall can rapidly lead to aneurysm induction through...
9.
Hauck S, Kupferthaler A, Freund M, Pichler P, Stelzmuller M, Burghuber C, et al.
Insights Imaging
. 2022 Mar;
13(1):62.
PMID: 35347467
Objective: To present a case series of spontaneous structural failure of bridging stentgrafts (BSGs) after branched endovascular aortic repair (bEVAR), as well as their failure types and their detection. While...
10.
Kirchweger P, Kupferthaler A, Burghofer J, Webersinke G, Jukic E, Schwendinger S, et al.
Data Brief
. 2022 Mar;
41:107944.
PMID: 35242926
This data article subsumes the data acquiration process, analysis and results of 'Circulating tumor DNA correlates with tumor burden and predicts outcome in pancreatic cancer irrespective of tumor stage' published...